EUVIMEDEUVIMED entdecken
Übersichtsarbeit

99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review

Tohoru Takeda, Jin Wu, Thet-Thet Lwin

Recent Patents on Cardiovascular Drug Discovery · 2006

DOI: 10.2174/157489006777442496 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Cardiovascular Drug Discovery, 2006. Verfasst von Tohoru Takeda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken 305-…. Hauptthemen laut MEDLINE: Organophosphorus Compounds, Organotechnetium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In myocardial SPECT imaging with the popularly used 99mTc-sestamibi and 99mTc-tetrofosmin, intense liver uptake leads to a paradoxical decrease of counts in the absence of perfusion abnormalities, making it difficult to assess myocardial perfusion, particularly in the inferior or inferoapical left ventricular wall. 99mTc-N-DBODC5, which is a new lipophilic, mono-cationic nitride myocardial perfusion imaging agent, exhibits high myocardial uptake and excellent bio-distribution kinetics with rapid liver clearance in rats and dogs. 99mTc-N-DBODC5 myocardial imaging during vasodilator stress can determine the severity of stenosis, though underestimates occur with mild coronary stenosis compared to 201Tl, in a similar way to what occurs with 99mTc-sestamibi and 99mTc-tetrofosmin. In particular, 99mTc-N-DBODC5's rapid liver clearance, which may significantly reduce the photon scatter from the liver, allows for the reduction of artifactual decreased myocardial perfusion and the improvement of the diagnostic accuracy of coronary artery disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organophosphorus CompoundsOrganotechnetium CompoundsAnimalsCoronary Artery DiseaseCoronary CirculationCoronary StenosisDogsHeartHumansLiverTechnetium Tc 99m SestamibiTissue DistributionTomography, Emission-Computed, Single-Photon

Substanzen

99mTc-N-DBODC5Organophosphorus CompoundsOrganotechnetium Compoundstechnetium tc-99m tetrofosminTechnetium Tc 99m Sestamibi

Autor:innen und Institutionen

  • Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken 305-8575, Japan. ttakeda@md.tsukuba.ac.jp

Zitieren

APA

Takeda, T., Wu, J., & Lwin, T. T. (2006). 99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review. Recent Patents on Cardiovascular Drug Discovery. https://doi.org/10.2174/157489006777442496

Vancouver

Takeda T, Wu J, Lwin TT. 99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review. Recent Patents on Cardiovascular Drug Discovery. 2006. doi:10.2174/157489006777442496

BibTeX
@article{Takeda2006,
  author = {Takeda, Tohoru and Wu, Jin and Lwin, Thet-Thet},
  title = {99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review},
  journal = {Recent Patents on Cardiovascular Drug Discovery},
  year = {2006},
  doi = {10.2174/157489006777442496}
}
Kostenlos starten →